» Authors » Myrddin Rees

Myrddin Rees

Explore the profile of Myrddin Rees including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 3451
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Welsh F, Sundaravadanan S, Sethi P, Kazeroun M, Fichera A, Nadziruddin I, et al.
HPB (Oxford) . 2025 Jan; PMID: 39827007
Background: The optimal strategy for patients with colorectal liver metastases (CRLM) is unclear. The Precision1 prospective, observational trial assessed whether pre-operative functional imaging and whole genome sequencing (WGS), could enhance...
2.
Sundaravadanan S, Welsh F, Sethi P, Noorani S, Cresswell B, Connell J, et al.
HPB (Oxford) . 2024 Mar; 26(6):764-771. PMID: 38480098
Background: Optimisation of the future liver remnant (FLR) is crucial to outcomes of extended liver resections. This study aimed to assess the quality of the FLR before and after dual...
3.
Chouari T, Merali N, La Costa F, Santol J, Chapman S, Horton A, et al.
Cancers (Basel) . 2023 Oct; 15(19). PMID: 37835557
Liver biopsy remains the gold standard for the histological assessment of the liver. With clear disadvantages and the rise in the incidences of liver disease, the role of neoadjuvant chemotherapy...
4.
Parmar K, OReilly D, Valle J, Braun M, Malcomson L, Jones R, et al.
BMJ Open . 2023 Mar; 13(3):e059369. PMID: 36997247
Introduction: Liver resection is the only curative treatment for colorectal liver metastases (CLM). Resectability decision-making is therefore a key determinant of outcomes. Wide variation has been demonstrated in resectability decision-making,...
5.
Welsh F, Walsh C, Chandrakumaran K, Rathnaweera W, Roy A, Needham J, et al.
HPB (Oxford) . 2022 Oct; 25(1):63-72. PMID: 36253269
Background: Routine chemical venous thromboembolism (VTE) prophylaxis for liver surgery remains controversial, and often delayed post-operatively due to perceived bleeding risk. This study asked whether patients undergoing hepatectomy for colorectal...
6.
Welsh F, Connell J, Kelly M, Gooding S, Banerjee R, Rees M
BMJ Open . 2022 Apr; 12(4):e057163. PMID: 35383076
Introduction: Radiogenomic analysis of patients being considered for liver resection is seldom performed in the clinic despite recent evidence indicating that quantitative MRI could improve posthepatectomy outcomes. Meanwhile, the increasingly...
7.
Sethi P, Thavanesan N, Welsh F, Connell J, Pickles E, Kelly M, et al.
BJR Case Rep . 2021 Jun; 7(3):20200172. PMID: 34131498
It is not uncommon for clinicians to encounter varying degrees of hepatic steatosis in patients undergoing resection for colorectal liver metastases (CRLM). Magnetic resonance imaging is currently the preferred investigation...
8.
Mole D, Fallowfield J, Sherif A, Kendall T, Semple S, Kelly M, et al.
PLoS One . 2020 Dec; 15(12):e0238568. PMID: 33264327
The risk of poor post-operative outcome and the benefits of surgical resection as a curative therapy require careful assessment by the clinical care team for patients with primary and secondary...
9.
Bridgewater J, Pugh S, Maishman T, Eminton Z, Mellor J, Whitehead A, et al.
Lancet Oncol . 2020 Feb; 21(3):398-411. PMID: 32014119
Background: The interim analysis of the multicentre New EPOC trial in patients with resectable colorectal liver metastasis showed a significant reduction in progression-free survival in patients allocated to cetuximab plus...
10.
Mole D, Fallowfield J, Kendall T, Welsh F, Semple S, Bachtiar V, et al.
BMC Cancer . 2018 Sep; 18(1):890. PMID: 30208871
Background: Accurate assessment of liver health prior to undertaking resectional liver surgery or chemoembolisation for primary and secondary cancers is essential for patient safety and optimal outcomes. LiverMultiScan™, an MRI-based...